What can current stimulation tell us about the vascular function of endogenous prostacyclin in healthy rat skin in vivo

Journal of Investigative Dermatology

Volumn 131, Issue 1, 2011, Pages 237-244

  Gohin, Stéphanie ^a   Sigaudo Roussel, Dominique ^a   Conjard Duplany, Agnès ^a   Dubourg, Laurence ^a   Saumet, Jean Louis ^a   Fromy, Bérengère ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; 9,11 AZOPROSTA 5,13 DIENOIC ACID; ACETIC ACID; ACETYLSALICYLIC ACID; CAY 1044; CAY 10441; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; METHYL ACETATE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; IN VIVO STUDY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SKIN BIOPSY; VASODILATATION;

EID: 78650276701     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.267     Document Type: Article

References (53)

1. Akan M, Cakir B, Misirlioglu A et al. (2005) Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg 39:7-10
2. Atar S, Ye Y, Lin Y et al. (2006) Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol 290:H1960-8
3. Bayorh MA, Eatman D, Walton M et al. (2002) Post-suspension hypotension is attenuated in Sprague-Dawley rats by prostacyclin synthase inhibition. Prostaglandins Leukot Essent Fatty Acids 66:511-7
4. Berliner MN (1997) Skin microcirculation during tapwater iontophoresis in humans: cathode stimulates more than anode. Microvasc Res 54:74-80
5. Cheng Y, Austin SC, Rocca B et al. (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539-41
6. De Graaf JC, Banga JD, Moncada S et al. (1992) Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85:2284-90
7. Durand S, Fromy B, Bouye P et al. (2002a) Current-induced vasodilation during water iontophoresis (5min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms. J Vasc Res 39:59-71
8. Durand S, Fromy B, Bouye P et al. (2002b) Vasodilatation in response to repeated anodal current application in the human skin relies on aspirin-sensitive mechanisms. J Physiol 540:261-9
9. Durand S, Fromy B, Koitka A et al. (2002c) Oral single high-dose aspirin results in a long-lived inhibition of anodal current-induced vasodilata-tion. Br J Pharmacol 137:384-90
10. Durand S, Fromy B, Tartas M et al. (2003) Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators. Am J Physiol Regul Integr Comp Physiol 285:R155-61
11. Edstrom LE, Balkovich M, Slotman GJ (1988) Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. Ann Plast Surg 20:106-11
12. Fitzgerald GA (2004) Coxibs and cardiovascular disease. N Engl J Med 351:1709-11
13. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-5
14. Gaubert ML, Sigaudo-Roussel D, Tartas M et al. (2007) Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice. J Physiol 585:617-26
15. Gauthier TW, Scalia R, Murohara T et al. (1995) Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hyper-cholesterolemia. Arterioscler Thromb Vasc Biol 15:1652-9
16. Grossmann M, Jamieson MJ, Kellogg DL Jr et al. (1995) The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyperemia. Microvasc Res 50:444-52
17. Hachulla E, Launay D, Hatron PY (2008) Iloprost for the treatment of systemic sclerosis. Presse Med 37:831-9
18. Holowatz LA, Thompson-Torgerson CS, Kenney WL (2008) The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 105:370-2
19. IJzerman RG, de Jongh RT, Beijk MA et al. (2003) Individuals at increased coronary heart disease risk are characterized by an impaired micro-vascular function in skin. Eur J Clin Invest 33:536-42
20. Kampfer H, Brautigam L, Geisslinger G et al. (2003) Cyclooxygenase-1- coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. J Invest Dermatol 120:880-90
21. Kellogg DL Jr, Zhao JL, Coey U et al. (2005) Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 98:629-32
22. Khan F, Davidson NC, Littleford RC et al. (1997) Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc Med 2:82-6
23. Knock GA, Terenghi G, Bunker CB et al. (1993) Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis. J Invest Dermatol 101:73-8
24. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-5
25. Lenasi H, Strucl M (2008) The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity. Eur J Appl Physiol 103:719-26
26. Leong J, Hughes-Fulford M, Rakhlin N et al. (1996) Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 224:79-87
27. Liou JY, Shyue SK, Tsai MJ et al. (2000) Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem 275:15314-20
28. Mantyh PW, Clohisy DR, Koltzenburg M et al. (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201-9
29. Marcelin-Jimenez G, Escalante B (2001) Functional and cellular interactions between nitric oxide and prostacyclin. Comp Biochem Physiol C Toxicol Pharmacol 129:349-59
30. Marie I, Beny JL (2002) Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 119:1379-87
31. Maurer B, Busch N, Jungel A et al. (2009) Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120:2367-76
32. Mollace V, Muscoli C, Masini E et al. (2005) Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57:217-52
33. Morris SJ, Shore AC (1996) Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 496:531-42
34. Murata T, Ushikubi F, Matsuoka T et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678-82
35. Noon JP, Walker BR, Hand MF et al. (1998) Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol 45:545-50
36. Ozyazgan I, Tercan M, Melli M et al. (1998) Eicosanoids and inflammatory cells in frostbitten tissue: prostacyclin, thromboxane, polymorpho-nuclear leukocytes, and mast cells. Plast Reconstr Surg 101:1881-6
37. Patrono C, Pugliese F, Ciabattoni G et al. (1982) Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 69:231-9
38. Reilly IA, Roy L, Fitzgerald GA (1986) Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) 292:1037-9
39. Robson MC, DelBeccaro EJ, Heggers JP et al. (1980) Increasing dermal perfusion after burning by decreasing thromboxane production. J Trauma 20:722-5
40. Rousseau P, Tartas M, Fromy B et al. (2008) Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 294:R1420-6
41. Rustin MH, Bull HA, Machin SJ et al. (1987) Serum from patients with Raynaud's phenomenon inhibits prostacyclin production. J Invest Dermatol 89:555-9
42. Sgonc R, Gruschwitz MS, Dietrich H et al. (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98:785-92
43. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endo-peroxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-60
44. Sugimoto M, Arai I, Futaki N et al. (2006) Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. Prostaglandins Leukot Essent Fatty Acids 75:1-8
45. Tabrizi-Fard MA, Fung HL (1996) Pharmacokinetics and steady-state tissue distribution of L- and D-isomers of nitroarginine in rats. Drug Metab Dispos 24:1241-6
46. Tartas M, Bouye P, Koitka A et al. (2005a) Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade. Am J Physiol Heart Circ Physiol 288:H1668-73
47. Tartas M, Bouye P, Koitka A et al. (2005b) Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms. J Appl Physiol 99:1538-44
48. Topper JN, Cai J, Falb D et al. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxy-genase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93:10417-22
49. Von Der Weid PY, Hollenberg MD, Fiorucci S et al. (2004) Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. Circulation 110:1320-5
50. Warren JB (1994) Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 8:247-51
51. Westerman RA, Widdop RE, Hogan C et al. (1987) Non-invasive tests of neurovascular function: reduced responses in diabetes mellitus. Neurosci Lett 81:177-82
52. Wu KK (1995) Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33:179-207
53. Yamada Y, Yamauchi D, Usui H et al. (2008) Hypotensive activity of novokinin, a potent analogue of ovokinin(2-7), is mediated by angiotensin AT(2) receptor and prostaglandin IP receptor. Peptides 29:412-8